2025 annual financial data
MBX Biosciences 2025 Operating margin
MBX Biosciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -98,055,000 USD and net income was -86,971,000 USD.
Operating cash flow was -79,949,000 USD.
Get free MBX Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -98,055,000 USD
- Net income
- -86,971,000 USD
- Operating cash flow
- -79,949,000 USD